company dedicated to advancing
differentiated, novel medicines
for hematologic malignancies
and other forms of cancer.
FORUS Therapeutics is thrilled to welcome Elaine Lai as an Intern through the Pharmaceutical & Healthcare Management and Innovation graduate program from Queen’s University. Elaine is a registered pharmacist, working closely with patients and healthcare providers...
Despite all the global and local challenges; related and unrelated to the pandemic, 2021 has been a year of tremendous growth, progress and development at FORUS. We are excited about 2022 and look forward to fulfilling our mission by bringing innovative new medicines...
In recognition of this last day of September and the close of Blood Cancer Awareness Month, FORUS Therapeutics Inc. is pleased to announce that Health Canada has accepted for review the New Drug Submission (NDS) for once-weekly XPOVIO® (selinexor) in combination with...
200 North Service Road West, Suite 129
Oakville, Ontario, L6M 2Y1